跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 49.3% - HSA Drug Approval Details
Approvals
/
HSA
/
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 49.3%
Approved
THERAPEUTIC
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 49.3%
SIEGFRIED HAMELN GMBH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
May 21, 1991
Approval ID
6028999877225ed5
Company
SIEGFRIED HAMELN GMBH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
6028999877225ed5
Drug Name
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 49.3%
Product Name
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION 49.3%
Approval Number
SIN05860P
Approval Date
1991-05-21
Registrant
PFIZER PRIVATE LIMITED
Licence Holder
PFIZER PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
B05XA05
Atc Item Name
magnesium sulfate
Pharma Manufacturer Name
PFIZER PRIVATE LIMITED
Active Ingredients
MAGNESIUM SULPHATE
2.47 g/5 ml
MAGNESIUM SULPHATE
2.47 G/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 21, 1991
Approval ID
6028999877225ed5
Type
Therapeutic
Back to HSA Approvals
